Publishing research using ab205270? Please let us know so that we can cite the reference in this datasheet.

ab205270 has been referenced in 7 publications.

  • Turunen SP  et al. FGFR4 phosphorylates MST1 to confer breast cancer cells resistance to MST1/2-dependent apoptosis. Cell Death Differ N/A:N/A (2019). PubMed: 30903103
  • Lodge EJ  et al. Homeostatic and tumourigenic activity of SOX2+ pituitary stem cells is controlled by the LATS/YAP/TAZ cascade. Elife 8:N/A (2019). PubMed: 30912742
  • Yan H  et al. Long noncoding RNA MLK7-AS1 promotes ovarian cancer cells progression by modulating miR-375/YAP1 axis. J Exp Clin Cancer Res 37:237 (2018). PubMed: 30249278
  • Zheng CH  et al. Inhibition of CXCR4 regulates epithelial mesenchymal transition of NSCLC via the Hippo-YAP signaling pathway. Cell Biol Int 42:1386-1394 (2018). PubMed: 29972256
  • Shu B  et al. Serotonin and YAP/VGLL4 Balance Correlated with Progression and Poor Prognosis of Hepatocellular Carcinoma. Sci Rep 8:9739 (2018). PubMed: 29950605
  • Li L  et al. The inhibition of Hippo/Yap signaling pathway is required for magnesium isoglycyrrhizinate to ameliorate hepatic stellate cell inflammation and activation. Biomed Pharmacother 106:83-91 (2018). PubMed: 29957470
  • Hernandez C  et al. HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest 128:2436-2451 (2018). PubMed: 29558367

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up